Company: INDP
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001641172-25-006429
Chunk: 57

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 57
---
 a stock option or satisfy any 
 tax withholding requirements are added back to the share reserve and again are available   
 for issuance under the 2021 Plan.                                                          |
| ● | Awards                                                                                     
 issued in substitution for awards previously granted by a company that merges with, or is  
 acquired by, the company do not reduce the share reserve limit under the 2021 Plan.        |

Director Compensation.
The 2021 Plan provides for an annual limit on non-employee director compensation of $750,000, increased to $1,000,000 in the fiscal year
of a non-employee director’s initial service as a non-employee member of the Board. This limit applies to the sum of both equity
grants that could be awarded to non-employee directors during a fiscal year (based on their value under ASC Topic 718 on the grant date)
and cash compensation, such as cash retainers and meeting fees earned during a fiscal year. Notwithstanding the foregoing, the plan administrator
reserves the right to make an exception to these limits due to extraordinary circumstances, with any such decision to be made without
the participation of the affected director receiving the additional compensation.

Stock Options.
Both ISOs (which are entitled to potentially favorable tax treatment) and nonqualified stock options (“NQSOs”) may be granted
under the 2021 Plan. The plan administrator will determine the vesting schedule and number of shares covered by each stock option granted
to a participant. The stock option exercise price is determined at grant by the plan administrator and must be at least 100% of the fair
market value of a share of common stock on the date of grant (110% for ISOs granted to stockholders who own more than 10% of the total
outstanding shares of the company, its parent or any of its subsidiaries). The term of a stock option shall not exceed 10 years from
the date of grant (or 5 years for ISOs granted to stockholders who own more than 10% of the total outstanding shares of the company,
its parent or any of its subsidiaries).

Stock Appreciation Rights. Stock appreciation rights may be granted under the 2021 Plan. The plan administrator will determine the vesting schedule
and number of shares covered by each stock appreciation right granted to a participant. The stock appreciation right exercise price is
determined at grant by the plan administrator and must be at least 100% of the fair market value of a share of common stock on the date
of grant.